Endobronchial Gene Therapy

Robert J. Kruklitis; Daniel H. Sterman

doi:10.1055/s-2004-832716

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2004; 25(4): 433-442
DOI: 10.1055/s-2004-832716

Endobronchial Gene Therapy

Robert J. Kruklitis¹ , Daniel H. Sterman¹

¹Interventional Pulmonology Program, Thoracic Oncology Research Laboratory, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Abstract

Gene therapy for pulmonary disease, a field still in the experimental stage, has nonetheless progressed considerably in the past decade. There have been significant advances in pre-clinical studies, as well as important developments resulting from multiple early-phase human clinical trials for a variety of respiratory disorders. Although there are several ways of delivering therapeutic genes to the lungs, the primary delivery modality remains flexible bronchoscopy. The flexible bronchoscope, because of its unique access to both large and small airways, serves as an ideal instrument to deliver therapeutic genes to the tracheobronchial tree, even to small airways and alveoli that are beyond the reach of the bronchoscope. In addition, bronchoscopic gene delivery has the capacity to treat pulmonary vascular disorders because delivery of marker and therapeutic genes via the airways has been demonstrated to successfully transduce the pulmonary vascular endothelium. This article describes the various methods and disease targets of bronchoscopically mediated gene therapy, focusing in particular on the results of clinical studies and providing a glimpse into the future of the field.

KEYWORDS

Gene therapy - vector - transgene - transduction - bronchoscopy

Full Text

References

REFERENCES

1 Albelda S M. Lung biology in health and disease. In: Albelda SM Gene Therapy in Lung Disease. Vol 169 New York; Marcel Dekker 2002: 555
2 Janssens S P, Bloch K D, Nong Z, Gerard R D, Zoldhelyl P, Collen D. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest. 1996; 98 317-324
3 Budts W, Pokreisz P, Nong Z. Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation. 2000; 102 2880-2885
4 Albelda S M, Wiewrodt R, Sterman D H. Gene therapy for lung neoplasms. Clin Chest Med. 2002; 23 265-277
5 Crystal R G. Transfer of genes to humans: early lessons and obstacles to success. Science. 1995; 270 404-410
6 Woolf A S, Bosch R J, Fine L G. Gene transfer into the mammalian kidney: microtransplantation of retrovirus-transduced metanephric tissue. Exp Nephrol. 1993; 1 41-48
7 Higaki J, Morishita R, Tomita N . Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun. 1992; 186 129-134
8 Danko I, Wolff J A. Direct gene transfer into muscle. Vaccine. 1994; 12 1499-1502
9 Beck S E, Laube B L, Adams R. Deposition of aerosolized AAV vectors in the lungs of rhesus macaques. Pediatr Pulmonol. 1999; 28(suppl 19);A228 227-245
10 Cipolla D C, Gonda I, Shak S, Kovesdi I, Crystal R, Sweeney T D. Coarse spray delivery to a localized region of the pulmonary airways for gene therapy. Hum Gene Ther. 2000; 11 361-371
11 Harvey B G, Hackett N R, Ely S, Crystal R. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals. Mol Ther. 2001; 3 206-215
12 Beck S E, Laube B L, Barberena C I et al.. Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. Mol Ther. 2002; 6 546-554
13 Harvey B G, Leopold P L, Hackett N R et al.. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest. 1999; 104 1245-1255
14 Flotte T R, Laube B L. Gene therapy in cystic fibrosis. Chest. 2001; 120(suppl 3) 124S-131S
15 Pilewski J M. Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency. Am J Respir Cell Mol Biol. 2002; 27 117-121
16 Davis P B, Drumm M, Konstan M W. Cystic fibrosis. Am J Respir Crit Care Med. 1996; 154 1229-1256
17 Smith J J, Travis S M, Greenberg E P, Welsh M J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996; 85 229-236
18 Goldman M J, Anderson G M, Stolzenberg E D et al.. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell. 1997; 88 553-560
19 Boat T F, Welsh M J, Beaudet A L. The metabolic basis of inherited disease. In: Scriver CR, Stanbury JB, Frederickson DS, Wingarden JB Cystic Fibrosis. 6th ed. New York; McGraw-Hill 1989
20 Johnson L G, Olsen J C, Saikadi B, Moore K L, Swanstrom R, Boucher R C. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet. 1992; 2 21-25
21 Boyles S C, Wilson J, Boucher R C, Johnson L G. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest. 1995; 95 1377-1382
22 Jaffe A, Brody S, Crystal R G et al.. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum Gene Ther. 1995; 6 643-666
23 Robinson C B, McCoy K S, Zuckerman J B et al.. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther. 1999; 10 2973-2985
24 Morris J E, Pavelka K, Perricone M A et al.. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis, II: Transfection efficiency in airway epithelium. Hum Gene Ther. 2001; 12 1383-1394
25 O'Sullivan B P, Lapey A, Joseph P M et al.. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis, I: Methods, safety, and clinical implications. Hum Gene Ther. 2001; 12 1369-1382
26 Flotte T R, Carter B J. In vivo gene therapy with adeno-associated virus vectors for cystic fibrosis. Adv Pharmacol. 1997; 40 85-101
27 McVeigh U, Flotte T R, Guggino W B, Zeitlin P L, Rubenstein R C. CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector. Gene Ther. 1997; 4 384-392
28 Conrad C K, Allen S S, Afione S A et al.. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 1996; 3 658-668
29 Flotte T, Carter B, Conrad C et al.. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther. 1996; 7 1145-1159
30 Aitken M L, Moss R B, Waltz D A et al.. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther. 2001; 12 1907-1916
31 Ruiz F E, Clancy J P, Perricone M A et al.. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther. 2001; 12 751-761
32 Lipshutz G S, Flebbe-Rehwaldt L, Gaensler K M. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol Ther. 2000; 2 374-380
33 Boyle M P, Enke R A, Adams R J, Guggino W B, Zeitlin P L. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol Ther. 2001; 4 115-121
34 Sylvester K G, Yang E Y, Cass D L, Crombelhome T M, Adzick N S. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg. 1997; 32 964-969
35 Swisher S G, Roth J A, Carbone D P. Genetic and immunologic therapies for lung cancer. Semin Oncol. 2002; 29(1 suppl 4) 95-101
36 Sager R. Tumor suppressor genes: the puzzle and the promise. Science. 1989; 246 1406-1412
37 Takahashi T, Nau M M, Chiba I et al.. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989; 246 491-494
38 Chiba I, Takahashi T, Nau M M et al.. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. 1990; 5 1603-1610
39 Carbone D P, Minna J D. The molecular genetics of lung cancer. Adv Intern Med. 1992; 37 153-171
40 Roth J A. Gene replacement strategies for lung cancer. Curr Opin Oncol. 1998; 10 127-132
41 Rizk N P, Chang M Y, El Kouri C et al.. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer. Cancer Gene Ther. 1999; 6 291-301
42 Van Meir E G, Roemev K, Diserens A C et al.. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet. 1994; 8 171-176
43 Fukazawa T, Fujiwara T, Morimoto Y et al.. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Oncogene. 1999; 18 2189-2199
44 Roth J A, Nguyen D, Lawrence D D et al.. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med. 1996; 2 985-991
45 Schuler M, Rochlitz C, Horowitz J A et al.. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther. 1998; 9 2075-2082
46 Swisher S G, Roth J A, Nemunaitis J et al.. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999; 91 763-771
47 Yen N, Iaonnides C G, Xu K et al.. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther. 2000; 7 530-536
48 Nemunaitis J, Swisher S G, Timmons T et al.. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol. 2000; 18 609-622
49 Weill D, Mack M, Roth J et al.. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection. Chest. 2000; 118 966-970
50 Schuler M, Herrmann R, DeGreve J L et al.. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol. 2001; 19 1750-1758
51 Swisher S G, Roth J A, Komaki R et al.. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res. 2003; 9 93-101
52 Spitz F R, Nguyen D, Skibber J M, Meyn R E, Christiano R J, Roth J A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res. 1996; 2 1665-1671
53 Kubba S, Adak S, Schiller J. Phase I trial of adenovirus p53 in bronchioalveolar cell lung carcinoma (BAC) administered by bronchoalveolar lavage. Proc Am Soc Clin Onc. 2000; 19 , Abstract 1904
54 Ludington L G, Verska J J, Howard T, Kupridakis G, Brewer III L A. Bronchiolar carcinoma (alveolar cell), another great imitator; a review of 41 cases. Chest. 1972; 61 622-628
55 Delarue N C, Anderson W, Sanders D, Starr J. Bronchiolo-alveolar carcinoma: a reappraisal after 24 years. Cancer. 1972; 29 90-97
56 Barkley J E, Green M R. Bronchioloalveolar carcinoma. J Clin Oncol. 1996; 14 2377-2386
57 Dubinett S M, Miller P W, Sharma S, Batra R K. Gene therapy for lung cancer. Hematol Oncol Clin North Am. 1998; 12 569-594
58 Tursz T, Cesne A L, Baldeyrou P et al.. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst. 1996; 88 1857-1863
59 Gahery-Segard H, Molinier-Frenkel V, LeBoulaire C et al.. Phase I trial of recombinant adenovirus gene transfer in lung cancer: longitudinal study of the immune responses to transgene and viral products. J Clin Invest. 1997; 100 2218-2226
60 Odaka M, Sterman D H, Wiewrodt R et al.. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Cancer Res. 2001; 61 6201-6212
61 Stoller J K. Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture. Chest. 1997; 111(suppl 6) 123S-128S
62 Canonico A E, Conary J T, Meyrick B O, Brigham K L. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol. 1994; 10 24-29
63 Rosenfeld M A, Siegfried W, Yoshimura K et al.. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science. 1991; 252 431-434
64 Hogan S P, Foster P S, Tan X, Ramsay A J. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol. 1998; 28 413-423
65 Dow S W, Schwarz J, Heath T D, Potter T A, Gelfand E W. Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther. 1999; 10 1905-1914
66 Stampfli M R, Scott Neigh G, Wiley R E et al.. Regulation of allergic mucosal sensitization by interleukin-12 gene transfer to the airway. Am J Respir Cell Mol Biol. 1999; 21 317-326
67 Danel C, Erzurum S C, Prayssac P et al.. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther. 1998; 9 1487-1496
68 Epperly M, Bray J, Krager S et al.. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 1998; 5 196-208
69 Korst R J, Bewig B, Crystal R G. In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Hum Gene Ther. 1995; 6 277-287
70 Yei S, Bachurski C J, Weaver T E, Wert S E, Trapnell B C, Whitsett J A. Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells. Am J Respir Cell Mol Biol. 1994; 11 329-336
71 Chapelier A, Danel C, Mazmanian M et al.. Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum Gene Ther. 1996; 7 1837-1845
72 Sime P J, Xing Z, Graham F L, Caskie K G, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997; 100 768-776
73 Gauldie J, Sime P J, Xing Z, Marr B, Tremblay G M. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr Top Pathol. 1999; 93 35-45
74 Greenberger M J, Kunkel S L, Strieter R M et al.. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol. 1996; 157 3006-3012
75 Kolls J K, Lei D, Nelson S, Summer W R, Shellito J E. Pulmonary cytokine gene therapy: adenoviral-mediated murine interferon gene transfer compartmentally activates alveolar macrophages and enhances bacterial clearance. Chest. 1997; 111(suppl 6) 104S
76 Lei D, Lancaster J R, Joshi M S et al.. Activation of alveolar macrophages and lung host defenses using transfer of the interferon-gamma gene. Am J Physiol. 1997; 272(5 Pt 1) L852-L859
77 Standiford T J, Wilkowski J M, Sisson T H et al.. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum Gene Ther. 1999; 10 899-909
78 Condos R, Rom W N, Schluger N W. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet. 1997; 349 1513-1515
79 Kumar M, Behera A K, Lockey R F et al.. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther. 2002; 13 1415-1425
80 Kumar M, Behera A K, Natsuse H, Lockey R F, Mohapatra S S. Intranasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection. Vaccine. 1999; 18 558-567
81 Jiang C, Magee D M, Cox R A. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect Immun. 1999; 67 2996-3001
82 Kolls J K, Habetz S, Shean M K et al.. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J Immunol. 1999; 162 2890-2894
83 Jobe A H, Ikegami M, Yei S, Whitsett J A, Trapnell B. Surfactant effects on aerosolized and instilled adenoviral-mediated gene transfer. Hum Gene Ther. 1996; 7 697-704
84 Katkin J P, Husser R C, Langston C, Welty S E. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther. 1997; 8 171-176
85 Stern M, Caplan N J, Browning J E et al.. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 1998; 5 91-98
86 Kitson C, Angel B, Judd D et al.. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 1999; 6 534-546
87 Parsons D W, Grubb B R, Johnson L G, Boucher R C. Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum Gene Ther. 1998; 9 2661-2672
88 Wang G, Zabner J, Deering C et al.. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am J Respir Cell Mol Biol. 2000; 22 129-138
89 Coyne C B, Kelly M M, Boucher R C, Johnson L G. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol. 2000; 23 602-609
90 Fasbender A, Lee J H, Wolters R W, Moninger T O, Zabner J, Welsh M J. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest. 1998; 102 184-193
91 Lee J H, Zabner J, Welsh M J. Delivery of an adenovirus vector in a calcium phosphate coprecipitate enhances the therapeutic index of gene transfer to airway epithelia. Hum Gene Ther. 1999; 10 603-613
92 Walters R W, Duan D, Engelhardt J F, Welsh M J. Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo. J Virol. 2000; 74 535-540
93 Zabner J, Zeiher B G, Friedman E, Welsh M J. Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J Virol. 1996; 70 6994-7003
94 Seiler M P, Luner P, Moninger T O, Karp P H, Keshavjee S, Zabner J. Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia. Am J Respir Cell Mol Biol. 2002; 27 133-140
95 Kruklitis R J et al.. Stent-mediated gene transfer: a novel and efficient means of gene delivery to the tracheobronchial tree. AJRCCM. 2003; 167(suppl 7) A525
95a Rooney C P, Suter M, McLennan G et al.. Laser fluorescence bronchoscopy for detection of fluorescent reproter genes in airway epithelia. Gene Ther. 2002; 9 1639-1644
96 Flotte T R, Beck S E, Chestnut K, Potter M, Poirier A, Zolotukhin S. A fluorescence video-endoscopy technique for detection of gene transfer and expression. Gene Ther. 1998; 5 166-173

Daniel H StermanM.D.

833 West Gates Bldg., Hospital of the University of Pennsylvania

3600 Spruce St., Philadelphia

PA 19104

Email: sterman@mail.med.upenn.edu